Is hypertension a determinant of erythropoietin requirements in hemodialysis?
Statement of problem. Post-hoc analysis of results from a pilot study of erythropoietin (Epo) use in hemodialysis (HD) suggested that, to achieve a target hemaglobin (Hg) level, higher doses of Epo were required in patients with hypertension (HTN). There was a need to clarify the role of HTN in dete...
| Main Author: | |
|---|---|
| Format: | Others |
| Language: | en en_US |
| Published: |
2007
|
| Online Access: | http://hdl.handle.net/1993/2121 |